Skip to main content
. 2018 Sep 11;11(6):1379–1389. doi: 10.1016/j.tranon.2018.08.015

Table 1.

Overall Survival by Kaplan-Meier Estimate

Cancer Total No. of Samples Cases with Alteration (No.)
Cases without Alteration (No.)
References
Mutation Total Deceased MMS Total Deceased MMS
Adrenocortical carcinoma 88 - 1 0 NA 87 32 79.01 [64]
Bladder cancer 408 X84_splice 6 3 28.38 399 174 34.95 [65]
Breast invasive cancer 816 - 5 0 NA 809 118 129.6 [66]
482 - 1 0 NA 481 60 113.74 [67]
963 - 7 0 NA 954 135 129.6 [68]
Brain lower-grade glioma 283 - 4 1 25.89 278 71 75.1 [69]
Breast cancer 2051 - 35 16 163.1 1831 1075 152.9333333 [70]
BUC 127 - 1 0 NA 126 46 20.47 [71]
127 - 1 0 NA 125 61 23.19 [72]
Colorectal adenocarcinoma 212 D157N 2 0 NA 208 17 NA [73]
220 D157N 3 1 NA 216 38 NA [74]
Cholangiocarcinoma 35 - 1 0 NA 32 15 24.34 [75]
CSCCEA 191 X18_splice 3 1 NA 188 40 101.74 [76]
Esophageal carcinoma 184 - 15 7 44.71 169 69 25.76 [77]
Glioblastoma 281 - 8 6 10.8 238 157 13.1 [78]
Glioblastoma multiforme 273 - 9 7 10.81 259 204 13.63 [79]
HNSCC 279 - 7 5 71.16 152 64 21.75 [80]
504 - 18 10 30.91 484 205 56.44 [81]
RPCC 280 - 1 0 NA 278 41 NA [82]
RCCC 418 - 2 1 1.94 413 138 75.5 [83]
448 - 3 1 NA 445 151 90.41 [84]
LNDLBL 48 - 1 0 NA 47 9 211.07 [85]
OSC 311 - 10 8 50.33 299 197 44.51 [86]
Pancreatic adenocarcinoma 149 - 4 1 NA 145 81 19.65 [87]
Prostate adenocarcinoma 492 A161T, Q48 5 0 NA 487 9 NA [88]
Papillary thyroid carcinoma 399 - 1 0 NA 321 13 NA [89]
Stomach adenocarcinoma 287 - 8 1 18.33 217 53 30.88 [90]
393 - 17 6 37.88 369 133 35.97 [91]
Skin cutaneous melanoma 287 P28L, C162F 5 1 297.67 276 159 80.62 [92]
Sarcoma 243 Y13Tfs 30 3 1 NA 240 91 65.41 [93]
Testicular germ cell cancer 149 - 2 0 NA 131 4 NA [94]
Thyroid carcinoma 399 - 1 0 NA 398 14 NA [95]
UCEC 240 A161T, R106I 2 0 NA 237 23 NA [96]
242 A161T, R106I 3 0 NA 239 32 NA [97]
HHS Vulnerability Disclosure